{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T12:22:59Z","timestamp":1787574179753,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina de Familia. SEMERGEN"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.semerg.2026.102780","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T21:06:41Z","timestamp":1780607201000},"page":"102780","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Posicionamiento SEMERGEN en el manejo del paciente oncol\u00f3gico: abordaje integral de la cardiotoxicidad en Atenci\u00f3n Primaria"],"prefix":"10.1016","volume":"52","author":[{"given":"V.","family":"Pallar\u00e9s-Carratal\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Justel-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cinza-Sanjurjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"L\u00f3pez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tur\u00e9gano Yedro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ru\u00edz Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kafrnawi Nassar Kwifatie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Pe\u00f1a-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Zamora-Au\u00f1\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Higuera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"de Paz-Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"C\u00f3rdoba-Mascu\u00f1ano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Pascual-Izquierdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Ci\u00e9rvide-Jur\u00edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Moliner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pa\u00f1os-Babin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.D.","family":"Rodriguez-Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Maz\u00f3n-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semerg.2026.102780_bib0275","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.aprim.2016.04.001","article-title":"El m\u00e9dico de familia en la atenci\u00f3n al paciente con c\u00e1ncer","volume":"48","author":"L\u00f3pez Verde","year":"2016","journal-title":"Aten Primaria."},{"key":"10.1016\/j.semerg.2026.102780_bib0280","series-title":"Estrategia en C\u00e1ncer del Sistema Nacional de Salud: actualizaci\u00f3n aprobada por el Consejo Interterritorial del Sistema Nacional de Salud","year":"2021"},{"key":"10.1016\/j.semerg.2026.102780_bib0285","doi-asserted-by":"crossref","DOI":"10.1007\/s12094-025-04189-1","article-title":"Consensus document between oncology and primary care for the follow-up of cancer survivors","author":"Vidal-Tocino","year":"2026","journal-title":"Clin Transl Oncol."},{"key":"10.1016\/j.semerg.2026.102780_bib0290","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/ejhf.3102","article-title":"European Society of Cardiology Core Curriculum for cardio-oncology","volume":"26","author":"L\u00f3pez-Fern\u00e1ndez","year":"2024","journal-title":"Eur J Heart Fail."},{"key":"10.1016\/j.semerg.2026.102780_bib0295","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J."},{"key":"10.1016\/j.semerg.2026.102780_bib0300","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jaccao.2022.07.005","article-title":"Permissive Cardiotoxicity: The Clinical Crucible of Cardio-Oncology","volume":"4","author":"Porter","year":"2022","journal-title":"JACC CardioOncol."},{"key":"10.1016\/j.semerg.2026.102780_bib0305","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","article-title":"Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline","volume":"35","author":"Armenian","year":"2017","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.semerg.2026.102780_bib0310","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11864-021-00908-2","article-title":"The Importance of Primary Care in Cardio-Oncology","volume":"22","author":"Cehic","year":"2021","journal-title":"Curr Treat Options Oncol."},{"key":"10.1016\/j.semerg.2026.102780_bib0315","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J."},{"key":"10.1016\/j.semerg.2026.102780_bib0320","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.recesp.2016.12.021","article-title":"Cardio-Onco-Hematology in Clinical Practice Position Paper and Recommendations","volume":"70","author":"L\u00f3pez-Fern\u00e1ndez","year":"2017","journal-title":"Rev Esp Cardiol (Engl Ed)."},{"key":"10.1016\/j.semerg.2026.102780_bib0325","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1161\/HYP.0000000000000224","article-title":"Cancer Therapy-Related Hypertension: A Scientific Statement From the American Heart Association","volume":"80","author":"Cohen","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.semerg.2026.102780_bib0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clbc.2024.09.017","article-title":"Effective Strategies for the Prevention and Mitigation of Phosphatidylinositol-3-Kinase Inhibitor-Associated Hyperglycemia: Optimizing Patient Care","volume":"25","author":"Moore","year":"2025","journal-title":"Clin Breast Cancer."},{"key":"10.1016\/j.semerg.2026.102780_bib0335","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ctrv.2008.09.007","article-title":"Effects of hormonal treatment on lipids in patients with cancer","volume":"35","author":"Filippatos","year":"2009","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.semerg.2026.102780_bib0340","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1056\/NEJMoa2027187","article-title":"First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer","volume":"383","author":"Shaw","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.semerg.2026.102780_bib0345","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3390\/cancers13071712","article-title":"Breast Radiotherapy-Related Cardiotoxicity. When, How, Why. Risk Prevention and Control Strategies","volume":"13","author":"D\u00edaz-Gavela","year":"2021","journal-title":"Cancers."},{"key":"10.1016\/j.semerg.2026.102780_bib0350","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.recesp.2020.11.014","article-title":"Estratificaci\u00f3n, monitorizaci\u00f3n y control del riesgo cardiovascular en pacientes con c\u00e1ncer. Documento de consenso de SEC, FEC, SEOM, SEOR, SEHH, SEMG, AEEMT, AEEC y AECC","volume":"74","author":"Mart\u00edn Garc\u00eda","year":"2021","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.semerg.2026.102780_bib0355","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1093\/eurheartj\/ehy453","article-title":"Cardio-oncology services: rationale, organization, and implementation","volume":"40","author":"Lancellotti","year":"2019","journal-title":"Eur Heart J."},{"key":"10.1016\/j.semerg.2026.102780_bib0360","doi-asserted-by":"crossref","first-page":"e997","DOI":"10.1161\/CIR.0000000000000679","article-title":"Cardio-oncology rehabilitation to manage cardiovascular outcomes in cancer patients and survivors: a scientific statement from the American Heart Association","volume":"139","author":"Gilchrist","year":"2019","journal-title":"Circulation."},{"key":"10.1016\/j.semerg.2026.102780_bib0365","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/ejhf.1920","volume":"22","author":"Lyon","year":"2020","journal-title":"Eur J Heart Fail."},{"key":"10.1016\/j.semerg.2026.102780_bib0370","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/eurheartj\/ehae496","article-title":"Anthracycline-induced cardiovascular toxicity: validation of the Heart Failure Association and International Cardio-Oncology Society risk score","volume":"46","author":"Rivero-Santana","year":"2025","journal-title":"Eur Heart J."},{"key":"10.1016\/j.semerg.2026.102780_bib0375","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.annonc.2019.10.023","article-title":"Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations","volume":"31","author":"Curigliano","year":"2020","journal-title":"Ann Oncol."},{"key":"10.1016\/j.semerg.2026.102780_bib0380","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1177\/2047487319846715","volume":"26","author":"Rossello","year":"2019","journal-title":"Eur J Prev Cardiol."},{"key":"10.1016\/j.semerg.2026.102780_bib0385","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10549-021-06192-w","article-title":"Incidence of cardiotoxicity and validation of the Heart Failure Association\u2013International Cardio-Oncology Society risk stratification tool in patients treated with trastuzumab for HER2-positive early breast cancer","volume":"188","author":"Battisti","year":"2021","journal-title":"Breast Cancer Res Treat."},{"key":"10.1016\/j.semerg.2026.102780_bib0390","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/eurheartj\/ehaa006","article-title":"Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry","volume":"41","author":"L\u00f3pez-Send\u00f3n","year":"2020","journal-title":"Eur Heart J."},{"key":"10.1016\/j.semerg.2026.102780_bib0395","first-page":"46","article-title":"Hypertension in cardio-oncology clinic: an update on etiology, assessment, and management","volume":"9","author":"Askarinejad","year":"2023","journal-title":"Cardiooncology."},{"key":"10.1016\/j.semerg.2026.102780_bib0400","doi-asserted-by":"crossref","first-page":"297","DOI":"10.6004\/jnccn.2023.0013","article-title":"Smoking Cessation, Version 3.2022 NCCN Clinical Practice Guidelines in Oncology","volume":"21","author":"Shields","year":"2023","journal-title":"J Natl Compr Canc Netw."},{"key":"10.1016\/j.semerg.2026.102780_bib0405","doi-asserted-by":"crossref","first-page":"e811","DOI":"10.1161\/CIR.0000000000001056","article-title":"Cardio-oncology drug interactions: A Scientific Statement from the American Heart Association","volume":"145","author":"Beavers","year":"2022","journal-title":"Circulation."},{"key":"10.1016\/j.semerg.2026.102780_bib0410","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/CIR.0000000000001158","article-title":"Equity in cardio-oncology care and research: A Scientific Statement from the American Heart Association","volume":"148","author":"Addison","year":"2023","journal-title":"Circulation."},{"key":"10.1016\/j.semerg.2026.102780_bib0415","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update","volume":"38","author":"Key","year":"2020","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.semerg.2026.102780_bib0420","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1111\/jth.14219","article-title":"Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH","volume":"16","author":"Khorana","year":"2018","journal-title":"J Thromb Haemost."},{"key":"10.1016\/j.semerg.2026.102780_bib0425","doi-asserted-by":"crossref","first-page":"716","DOI":"10.6004\/jnccn.2008.0055","article-title":"Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncology","volume":"6","author":"Wagman","year":"2008","journal-title":"J Natl Compr Canc Netw."},{"key":"10.1016\/j.semerg.2026.102780_bib0430","doi-asserted-by":"crossref","first-page":"419","DOI":"10.6004\/jadpro.2023.14.5.7","article-title":"Managing drug interactions with oral anticancer treatments","volume":"14","author":"Lohr","year":"2023","journal-title":"J Adv Pract Oncol."},{"key":"10.1016\/j.semerg.2026.102780_bib0435","unstructured":"Drug Interactions - UpToDate [Internet]. [consultado 27 Feb 2026]. Disponible en: https:\/\/www-uptodate-com.m-hulp.a17.csinet.es\/drug-interactions\/#di-druglist."},{"key":"10.1016\/j.semerg.2026.102780_bib0440","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1249\/MSS.0000000000002116","article-title":"Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable","volume":"51","author":"Campbell","year":"2019","journal-title":"Med Sci Sports Exerc."},{"key":"10.1016\/j.semerg.2026.102780_bib0445","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.clnu.2021.02.005","article-title":"ESPEN practical guideline: Clinical Nutrition in cancer","volume":"40","author":"Muscaritoli","year":"2021","journal-title":"Clin Nutr."},{"key":"10.1016\/j.semerg.2026.102780_bib0450","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/bjc.2012.364","article-title":"Incidence and drug treatment of emotional distress after cancer diagnosis: a matched primary care case-control study","volume":"107","author":"Desplenter","year":"2012","journal-title":"Br J Cancer."},{"key":"10.1016\/j.semerg.2026.102780_bib0455","doi-asserted-by":"crossref","first-page":"37","DOI":"10.9734\/indj\/2025\/v22i1467","article-title":"Integrative psychocardiology: Strategies for managing mental and cardiac risks in oncology patients\u2019","volume":"22","author":"Cuthrell","year":"2025","journal-title":"Int Neuropsychiatr Dis J."},{"key":"10.1016\/j.semerg.2026.102780_bib0460","article-title":"Survivors of Oncological Disease: Experience and Satisfaction with National Health Care and Service","volume":"13","author":"Gaspar","year":"2025","journal-title":"Healthcare (Basel)."},{"key":"10.1016\/j.semerg.2026.102780_bib0465","doi-asserted-by":"crossref","first-page":"7343","DOI":"10.3390\/curroncol29100577","article-title":"The Association between Survivorship Care Plans and Patient-Reported Satisfaction and Confidence with Follow-Up Cancer Care Provided by Primary Care Providers","volume":"29","author":"Chu","year":"2022","journal-title":"Curr Oncol."},{"key":"10.1016\/j.semerg.2026.102780_bib0470","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/nursrep16010018","article-title":"Patient Voice and Treatment Nonadherence in Cancer Care: A Scoping Review of Sentiment Analysis","volume":"16","author":"Wreyford","year":"2026","journal-title":"Nurs Rep."},{"key":"10.1016\/j.semerg.2026.102780_bib0475","first-page":"2411","article-title":"Protocolo de tratamiento de la cardiotoxicidad en la Cardio-oncolog\u00eda","volume":"13","author":"Zatarain-Nicol\u00e1s","year":"2021","journal-title":"Medicine."},{"key":"10.1016\/j.semerg.2026.102780_bib0480","series-title":"SEC- PRIMARIA: Proceso Cardio-Onco-Hematologia","year":"2019"},{"key":"10.1016\/j.semerg.2026.102780_bib0485","year":"2024","journal-title":"C\u00e1ncer y Coraz\u00f3n: Estrategias coordinadas de prevenci\u00f3n, diagn\u00f3stico y tratamiento de la toxicidad cardiovascular"},{"key":"10.1016\/j.semerg.2026.102780_bib0490","article-title":"Gu\u00eda cl\u00ednica de Cardio-oncolog\u00eda: coordinaci\u00f3n multidisciplinar y toma de decisiones","year":"2026","journal-title":"SEOM."},{"key":"10.1016\/j.semerg.2026.102780_bib0495","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.3390\/curroncol29050261","article-title":"Risk Stratification and Cancer Follow-Up: Towards More Personalized Post-Treatment Care in Canada","volume":"29","author":"Urquhart","year":"2022","journal-title":"Curr Oncol."},{"key":"10.1016\/j.semerg.2026.102780_bib0500","doi-asserted-by":"crossref","DOI":"10.17061\/phrp31122108","article-title":"Challenges and solutions to sharing a cancer follow-up e-care plan between a cancer service and general practice","volume":"31","author":"Taggart","year":"2021","journal-title":"Public Health Res Pract."},{"key":"10.1016\/j.semerg.2026.102780_bib0505","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s11886-023-01906-6","article-title":"Cardio-oncology: Shared Genetic Metabolic, and Pharmacologic Mechanism","volume":"25","author":"Zhao","year":"2023","journal-title":"Curr Cardiol Rep."},{"key":"10.1016\/j.semerg.2026.102780_bib0510","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.mayocp.2024.08.014","article-title":"Cardiovascular Health Considerations for Primary Care Physicians Treating Breast Cancer Survivors","volume":"100","author":"Kidane","year":"2025","journal-title":"Mayo Clin Proc."},{"key":"10.1016\/j.semerg.2026.102780_bib0515","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023852","article-title":"Inequity in cardio-oncology: Identifying disparities in cardiotoxicity and links to cardiac and cancer outcomes","volume":"10","author":"Ohman","year":"2021","journal-title":"J Am Heart Assoc."},{"key":"10.1016\/j.semerg.2026.102780_bib0520","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/eurjpc\/zwaa034","article-title":"Cardiovascular risk factors during cancer treatment. Prevalence and prognostic relevance: insights from the CARDIOTOX registry","volume":"29","author":"Caro-Cod\u00f3n","year":"2022","journal-title":"Eur J Prev Cardiol."},{"key":"10.1016\/j.semerg.2026.102780_bib0525","unstructured":"SEC-Excelente. Proceso Cardio-Onco-Hematolog\u00eda. [consultado 27 Feb 2026]. Disponible en: https:\/\/secardiologia.es\/institucional\/reuniones-institucionales\/sec-calidad\/sec-excelente\/unidades-actuales\/14816-unidades-de-cardio-onco-hematologia."},{"key":"10.1016\/j.semerg.2026.102780_bib0530","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/j.jacc.2020.08.079","article-title":"Cardio-Oncology Leadership Council Cardio-Oncology Education and Training: JACC Council Perspectives","volume":"76","author":"Alvarez-Cardona","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.semerg.2026.102780_bib0535","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jaccao.2024.11.003","article-title":"Quality-of-Care Measures for Cardio-Oncology: An IC-OS and ACC Cardio-Oncology Leadership Council Perspective","volume":"7","author":"Rao","year":"2025","journal-title":"JACC CardioOncol."},{"key":"10.1016\/j.semerg.2026.102780_bib0540","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ehjqcco\/qcac070","article-title":"European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment","volume":"9","author":"Lee","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes."}],"container-title":["Medicina de Familia. SEMERGEN"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359326000973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359326000973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:33:34Z","timestamp":1787571214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1138359326000973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1138359326000973"],"URL":"https:\/\/doi.org\/10.1016\/j.semerg.2026.102780","relation":{},"ISSN":["1138-3593"],"issn-type":[{"value":"1138-3593","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Posicionamiento SEMERGEN en el manejo del paciente oncol\u00f3gico: abordaje integral de la cardiotoxicidad en Atenci\u00f3n Primaria","name":"articletitle","label":"Article Title"},{"value":"Medicina de Familia. SEMERGEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semerg.2026.102780","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedad Espa\u00f1ola de M\u00e9dicos de Atenci\u00f3n Primaria (SEMERGEN). Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102780"}}